What changed?
A sourced timeline of research records and material development changes tracked by BACToBasics for IGF-1 LR3. Research-publication dates and clinical-development event dates are labeled separately so they are not mistaken for the same type of update.
Tracked items
2
Research sources
1
Development entries
1
Latest recorded date
Verified 2026-09-05
Latest development activity
Verified 2026-09-05 · Preclinical / no established human program · No established development program
IGF-1 LR3 is discussed widely in research and performance communities, but a peer-reviewed clinical-development program for the exact analogue has not been established.
Open source ↗Latest research record by publication date
Published 2026 · Review · Evidence review
The review highlights the gap between established IGF-1 biology and the lack of meaningful direct human therapeutic evidence for IGF-1 LR3 itself.
Open source ↗Tracked timeline
Development changes are dated to the underlying milestone. Research-source entries use the study or source publication year currently stored in the Research Library; that year is not presented as the date BACToBasics added the record.
Preclinical / no established human program · No established development program
IGF-1 LR3 is discussed widely in research and performance communities, but a peer-reviewed clinical-development program for the exact analogue has not been established.
Review · Evidence review
The review highlights the gap between established IGF-1 biology and the lack of meaningful direct human therapeutic evidence for IGF-1 LR3 itself.
Following a compound creates a clean baseline from the updates currently known. When BACToBasics later records a new research source or material development change, the My Tools update badge can surface it as new for you.
BACToBasics provides educational research organization only. A development milestone does not predict future approval, and a research record does not establish that a compound is safe, effective, approved, or appropriate for use.